Related by context. Frequent words. (Click for all words.) 69 spokesman Tony Plohoros 65 Co MRK 61 http:/www.gsk.com 61 Co. BMY 61 www.gsk.com 60 http:/www.schering-plough.com 60 Nasdaq BIIB 60 Pfizer 60 Corp. Nasdaq GENZ 59 www.schering plough.com 59 spokesman Doug Petkus 57 NYSE PFE 57 www.vivus.com 57 Jean Marc Podvin 57 Corp BSX 57 Inc. Nasdaq SEPR 57 Ray Kerins 57 Analysts Upgrades Downgrades 56 nyse PFE news 56 Co. NYSE BMY 56 Canvaxin 56 GlaxoSmithKline plc NYSE 56 NYSE SGP 55 Chief Executive Jeffrey Kindler 55 Paul Fitzhenry 55 Co. NYSE MRK 55 Fablyn 55 analyst Jami Rubin 55 Bayer AG BAY GY 54 AstraZeneca PLC AZN 54 spokeswoman Carol Hively 54 clopidogrel bisulfate 54 Wellbutrin SR 54 gets USFDA nod 54 Vicuron Pharmaceuticals 54 Vytorin combines 54 Welcomes Analyst Initiation 54 Janet Skidmore 54 Gamble Quintiles sanofi aventis 54 Inc. Nasdaq TRMS 54 Chief Executive Werner Wenning 54 http:/www.lilly.com 54 Inc. NASDAQ CEPH 54 Inc. Nasdaq ARNA 54 TSX VRX 54 Ethyol 54 GlaxoSmithKline Plc GSK.L 53 Novartis 53 analyst Larry Biegelsen 53 PTK ZK 53 Tibotec Pharmaceuticals Ltd. 53 Roche Holding AG RHHBY 53 manufactures Cialis 53 R sorafenib tablets 53 PROFILE CO 53 treat nicotine addiction 53 Company Nasdaq PRGO 53 Corporation Nasdaq GENZ 53 analyst Mark Schoenebaum 53 GlaxoSmithKline PLC GSK 53 spokesman Peter Thonis 53 Pfizer PFE.N 53 experimental hepatitis C 53 nyse BMY news 53 Inc. PFE.N Quote 53 Invirase 53 programs visit http:/www.nih.gov 53 Myfortic 53 Bristol Myers Squibb 53 spokeswoman Kristin Huguet 53 Inc Therapeutic Competitors 52 Nasdaq AMLN 52 www.omnicare.com 52 GlaxoSmithKline 52 supplemental biologics 52 Sanofi Aventis 52 Amylin Pharmaceuticals Inc 52 Novartis AG NOVN.VX 52 antibiotic Ketek 52 antibiotic Zithromax 52 Earnings Scorecard 52 Geoffrey Porges 52 Advicor 52 Biogen IDEC 52 anidulafungin 52 Inspra 52 Shedlarz 52 Nasdaq AMGN 52 atorvastatin Lipitor 52 Recentin 52 http:/www.watson.com 52 Genentech Roche 52 Merck Schering 52 Bristol Myers NYSE BMY 52 By Nick Triggle 52 taranabant 52 Premarket Roundup 51 Inc. Nasdaq MYL 51 subsidiary Mylan Pharmaceuticals 51 Inc. FY# Q3 51 NASDAQ MYL